This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brattstrom, L. E. Articles by Hultberg, B. L. Search for Related Content PubMed PubMed Citation Articles by Brattstrom, L. E. Articles by Hultberg, B. L.

Stroke, Vol 15, 1012-1016, Copyright © 1984 by American Heart Association

ARTICLES

Moderate homocysteinemia--a possible risk factor for arteriosclerotic cerebrovascular disease

LE Brattstrom, JE Hardebo and BL Hultberg

Highly elevated concentrations of homocysteine measured as homocysteine or cysteine-homocysteine mixed disulfide (MDS) are found in plasma and urine in subjects with inherited abnormalities of the methionine metabolism. These subjects have a high incidence of arteriosclerotic vascular complications during childhood. Homocysteine causes endothelial cell injury and cell detachment that initiates the development of arteriosclerosis. The present study demonstrates a significantly elevated mean plasma MDS concentration in 19 patients with arteriosclerotic cerebrovascular disease compared to 17 controls. Our findings suggest that moderate homocysteinemia might be a risk factor for arteriosclerotic cerebrovascular disease.

This article has been cited by other articles:

				C. Wagner and M. J Koury S-Adenosylhomocysteine a better indicator of vascular disease than homocysteine? Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1581 - 1585. [Abstract] [Full Text] [PDF]

				V. Vitvitsky, A. Prudova, S. Stabler, S. Dayal, S. R. Lentz, and R. Banerjee Testosterone regulation of renal cystathionine beta-synthase: implications for sex-dependent differences in plasma homocysteine levels Am J Physiol Renal Physiol, August 1, 2007; 293(2): F594 - F600. [Abstract] [Full Text] [PDF]

				V. Vitvitsky, S. Dayal, S. Stabler, Y. Zhou, H. Wang, S. R. Lentz, and R. Banerjee Perturbations in homocysteine-linked redox homeostasis in a murine model for hyperhomocysteinemia Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2004; 287(1): R39 - R46. [Abstract] [Full Text] [PDF]

				P. J. Garlick The Nature of Human Hazards Associated with Excessive Intake of Amino Acids J. Nutr., June 1, 2004; 134(6): 1633S - 1639S. [Abstract] [Full Text] [PDF]

				J. F. Toole, M. R. Malinow, L. E. Chambless, J. D. Spence, L. C. Pettigrew, V. J. Howard, E. G. Sides, C.-H. Wang, and M. Stampfer Lowering Homocysteine in Patients With Ischemic Stroke to Prevent Recurrent Stroke, Myocardial Infarction, and Death: The Vitamin Intervention for Stroke Prevention (VISP) Randomized Controlled Trial JAMA, February 4, 2004; 291(5): 565 - 575. [Abstract] [Full Text] [PDF]

				Homocysteine Studies Collaboration Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis JAMA, October 23, 2002; 288(16): 2015 - 2022. [Abstract] [Full Text] [PDF]

				E. S Ford, S J. Smith, D. F Stroup, K. K Steinberg, P. W Mueller, and S. B Thacker Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies Int. J. Epidemiol., February 1, 2002; 31(1): 59 - 70. [Abstract] [Full Text] [PDF]

				G. J. Cuskelly, P. W. Stacpoole, J. Williamson, T. G. Baumgartner, and J. F. Gregory III Deficiencies of folate and vitamin B6 exert distinct effects on homocysteine, serine, and methionine kinetics Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1182 - E1190. [Abstract] [Full Text] [PDF]

				N. Matsuyama, M. Yamaguchi, M. Toyosato, M. Takayama, and K. Mizuno New Enzymatic Colorimetric Assay for Total Homocysteine Clin. Chem., December 1, 2001; 47(12): 2155 - 2156. [Full Text] [PDF]

				M. C. Polidori, A. Cherubini, U. Senin, and P. Mecocci Hyperhomocysteinemia and Oxidative Stress in Ischemic Stroke Stroke, January 1, 2001; 32(1): 275 - 278. [Full Text] [PDF]

				W. G. Christen, U. A. Ajani, R. J. Glynn, and C. H. Hennekens Blood Levels of Homocysteine and Increased Risks of Cardiovascular Disease: Causal or Casual? Arch Intern Med, February 28, 2000; 160(4): 422 - 434. [Abstract] [Full Text] [PDF]

				J. D. Spence, M. R. Malinow, P. A. Barnett, A. J. Marian, D. Freeman, and R. A. Hegele Plasma Homocyst(e)ine Concentration, But Not MTHFR Genotype, Is Associated With Variation in Carotid Plaque Area Stroke, May 1, 1999; 30(5): 969 - 973. [Abstract] [Full Text] [PDF]

				R. W. Powers, L. A. Minish, D. L. Lykins, R. B. Ness, W. R. Crombleholme, and J. M. Roberts Methylenetetrahydrofolate Reductase Polymorphism, Folate, and Susceptibility to Preeclampsia Reproductive Sciences, March 1, 1999; 6(2): 74 - 79. [Abstract] [PDF]

				L. Brattstrom, D. E. L. Wilcken, J. Ohrvik, and L. Brudin Common Methylenetetrahydrofolate Reductase Gene Mutation Leads to Hyperhomocysteinemia but Not to Vascular Disease : The Result of a Meta-Analysis Circulation, December 8, 1998; 98(23): 2520 - 2526. [Abstract] [Full Text] [PDF]

				Z. Chen and R. Banerjee Purification of Soluble Cytochrome b5 as a Component of the Reductive Activation of Porcine Methionine Synthase J. Biol. Chem., October 2, 1998; 273(40): 26248 - 26255. [Abstract] [Full Text] [PDF]

				K.S. Woo, P. Chook, Y.I. Lolin, A.S.P. Cheung, L.T. Chan, Y.Y. Sun, J.E. Sanderson, C. Metreweli, and D.S. Celermajer Hyperhomocyst(e)inemia Is a Risk Factor for Arterial Endothelial Dysfunction in Humans Circulation, October 21, 1997; 96(8): 2542 - 2544. [Abstract] [Full Text]

				G. R. Upchurch Jr., G. N. Welch, A. J. Fabian, J. E. Freedman, J. L. Johnson, J. F. Keaney Jr., and J. Loscalzo Homocyst(e)ine Decreases Bioavailable Nitric Oxide by a Mechanism Involving Glutathione Peroxidase J. Biol. Chem., July 4, 1997; 272(27): 17012 - 17017. [Abstract] [Full Text] [PDF]

				A. D'Angelo and J. Selhub Homocysteine and Thrombotic Disease Blood, July 1, 1997; 90(1): 1 - 11. [Full Text] [PDF]

				B. Lubec, O. Labudova, H. Hoeger, A. Muehl, S. Fang-Kircher, M. Marx, W. Mosgoeller, and J. Gialamas Homocysteine Increases Cyclin-Dependent Kinase in Aortic Rat Tissue Circulation, November 15, 1996; 94(10): 2620 - 2625. [Abstract] [Full Text]

				F. M.T. Loehrer, C. P. Angst, W. E. Haefeli, P. P. Jordan, R. Ritz, and B. Fowler Low Whole-Blood S-Adenosylmethionine and Correlation Between 5-Methyltetrahydrofolate and Homocysteine in Coronary Artery Disease Arterioscler. Thromb. Vasc. Biol., June 1, 1996; 16(6): 727 - 733. [Abstract] [Full Text]

				P. N. Hopkins, L. L. Wu, J. Wu, S. C. Hunt, B. C. James, G. M. Vincent, and R. R. Williams Higher Plasma Homocyst(e)ine and Increased Susceptibility to Adverse Effects of Low Folate in Early Familial Coronary Artery Disease Arterioscler. Thromb. Vasc. Biol., September 1, 1995; 15(9): 1314 - 1320. [Abstract] [Full Text]

				W. H. Giles, S. J. Kittner, R. F. Anda, J. B. Croft, and M. L. Casper Serum Folate and Risk for Ischemic Stroke : First National Health and Nutrition Examination Survey Epidemiologic Follow-up Study Stroke, July 1, 1995; 26(7): 1166 - 1170. [Abstract] [Full Text]

				A. Lindgren, L. Brattstrom, B. Norrving, B. Hultberg, A. Andersson, and B. B. Johansson Plasma Homocysteine in the Acute and Convalescent Phases After Stroke Stroke, May 1, 1995; 26(5): 795 - 800. [Abstract] [Full Text]

				M. A. Mansoor, C. Bergmark, A. M. Svardal, P. E. Lonning, and P. M. Ueland Redox Status and Protein Binding of Plasma Homocysteine and Other Aminothiols in Patients With Early-Onset Peripheral Vascular Disease : Homocysteine and Peripheral Vascular Disease Arterioscler. Thromb. Vasc. Biol., February 1, 1995; 15(2): 232 - 240. [Abstract] [Full Text]

				A. R. Riela and E. S. Roach Topical Review Article: Etiology of Stroke in Children J Child Neurol, July 1, 1993; 8(3): 201 - 220. [Abstract] [PDF]